Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring C<sub>6</sub>N<sub>6</sub> as an effective drug delivery carrier for anticancer drugs mercaptopurine and thiotepa: A DFT and MD approach.

Computational biology and chemistry·2026
Same author

Comment on "Role of social determinants and outcomes of patients with alcohol-associated liver disease referred for early liver transplantation: A multicenter analysis".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Serum ferritin as an adjunctive marker of dengue severity in the pediatric emergency department.

Frontiers in pediatrics·2026
Same author

Plasma and Intracellular Concentrations of Doxycycline and Azithromycin in Patients with Severe Scrub Typhus.

Antibiotics (Basel, Switzerland)·2026
Same author

Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor-Stratified Registry Analysis.

Clinical transplantation·2026
Same author

Total knee arthroplasty: use of robotic surgery versus conventional surgery: Scoping review.

Revista espanola de cirugia ortopedica y traumatologia·2026

Related Experiment Video

Updated: Jul 3, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Liver Transplantation for Biliary Atresia: Sex-Based Equity but Persistent Racial and Donor-Related Risk Factors.

Syeda Rabab Fatima1, Sohail Khan, Alejandro Chiodo Ortiz

  • 1>From the King Edward Medical University, Lahore, Pakistan.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|July 2, 2026
PubMed
Summary

Outcomes for pediatric liver transplants in biliary atresia show racial disparities in insurance, donor type, and graft failure. Black recipients faced higher risks, highlighting critical considerations for equitable care.

Related Experiment Videos

Last Updated: Jul 3, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Area of Science:

  • Pediatric Hepatology
  • Transplantation Immunology
  • Health Disparities Research

Background:

  • Biliary atresia is a leading indication for pediatric liver transplantation.
  • Liver transplantation serves as either primary or salvage therapy for affected children.
  • Understanding factors influencing transplant outcomes is crucial for improving patient survival.

Purpose of the Study:

  • To investigate the impact of recipient sex, race, and donor type on pediatric liver transplant outcomes.
  • To identify potential disparities in care and outcomes among children with biliary atresia.
  • To analyze graft failure and mortality rates based on demographic and donor characteristics.

Main Methods:

  • Retrospective analysis of 1382 pediatric liver transplant recipients with biliary atresia using the United Network for Organ Sharing database.
  • Comparison of outcomes based on sex, race, and donor type using statistical tests.
  • Graft failure and mortality analyzed using Kaplan-Meier curves and Cox regression.

Main Results:

  • No significant differences in outcomes were observed based on recipient sex.
  • Black and Hispanic recipients were more likely to have public insurance and higher initial disease severity scores.
  • Black recipients had reduced access to living donors and increased reliance on nationally shared organs, with Black race being a risk factor for graft failure in living donor transplants.

Conclusions:

  • Significant racial disparities exist in insurance status, donor access, and disease severity among pediatric biliary atresia patients undergoing liver transplantation.
  • These disparities, along with logistical factors, present critical challenges for achieving equitable management and improving outcomes.
  • Addressing these inequities is essential for optimizing liver transplant success in this vulnerable population.